文献速递胸部肿瘤

全外显子组关联研究识别与NSCLC患者生存相关的2p23.2和7p11.2低频编码变异

Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
PubMed 文献 · J Thorac Oncol · 2017-01-16

本研究在中国人群中开展全外显子组关联扫描,检测1008例NSCLC患者的247870个变异,并用癌症基因组图谱(TCGA)的插补基因型数据以Cox回归模型进行重复验证。结果显示CCT6A基因低频错义变异rs33922584与NSCLC生存显著相关,并在TCGA样本中得到重复验证;PLB1基因rs117512489在本研究样本中亦与生存相关,但仅获TCGA基因表达分析支持。

要点

  • CCT6A基因低频错义变异rs33922584与NSCLC患者生存显著相关(校正HR=1.75,p=6.06×10^-4)。
  • 该关联在TCGA样本中得到重复验证(校正HR=4.19,p=0.015)。
  • 基因水平与通路水平分析分别提示32个基因和34条潜在通路可能影响NSCLC生存。

核心结论

  • 低频或罕见变异在NSCLC患者生存中可能发挥重要作用,本研究为此提供了更多证据。

研究设计与样本

  • 研究在中国人群中开展全外显子组关联扫描,纳入1008例NSCLC患者,检测247870个变异。
  • 利用TCGA插补基因型数据,以Cox回归模型对候选变异进行重复验证。
  • 对非同义或剪接位点变异进行基因水平与通路水平分析,并用TCGA基因表达数据分析候选位点与基因。

主要发现

  • CCT6A基因低频错义变异rs33922584与NSCLC患者生存显著相关(校正HR=1.75,p=6.06×10^-4),并在TCGA样本中得到重复验证(校正HR=4.19,p=0.015)。
  • rs33922584的G等位基因与CCT6A高表达显著相关(p=0.019),CCT6A高表达在TCGA样本中可能与更差的生存相关(校正HR=1.15,p=0.047)。
  • PLB1基因rs117512489在本研究样本中与NSCLC患者生存相关(HR=2.02,p=7.28×10^-4),在TCGA中仅获基因表达分析支持(校正HR=1.15,p=0.023)。
  • 基因水平分析提示32个基因(包括CCT6A)可能与NSCLC生存相关,通路水平分析提示34条潜在通路可能影响NSCLC生存。

关键数值与推荐

  • CCT6A rs33922584:校正HR=1.75,p=6.06×10^-4(本研究样本);TCGA重复验证校正HR=4.19,p=0.015。
  • PLB1 rs117512489:HR=2.02,p=7.28×10^-4(本研究样本);TCGA基因表达分析校正HR=1.15,p=0.023。
  • rs33922584的G等位基因与CCT6A高表达相关(p=0.019);TCGA中CCT6A高表达校正HR=1.15,p=0.047。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • PLB1 rs117512489与生存的关联在本研究样本中显著,但仅获TCGA基因表达分析支持,未在TCGA中重复验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A growing body of evidence has suggested that low-frequency or rare coding variants might have strong effects on the development and prognosis of cancer. Here, we aim to assess the role of low-frequency and rare coding variants in the survival of NSCLC in Chinese populations. METHODS: We performed an exome-wide scan of 247,870 variants in 1008 patients with NSCLC and replicated the promising variants by using imputed genotype data of The Cancer Genome Atlas (TCGA) with a Cox regression model. Gene-based and pathway-based analysis were also performed for nonsynonymous or splice site variants. Additionally, analysis of gene expression data in the TCGA was used to increase the reliability of candidate loci and genes. RESULTS: A low-frequency missense variant in chaperonin containing TCP1 subunit 6A gene (CCT6A) (rs33922584: adjusted hazard ratio [HRadjusted] = 1.75, p = 6.06 × 10-4) was significantly related to the survival of patients with NSCLC, which was further replicated by the TCGA samples (HRadjusted = 4.19, p = 0.015). Interestingly, the G allele of rs33922584 was significantly associated with high expression of CCT6A (p = 0.019) that might induce the worse survival in the TCGA samples (HRadjusted = 1.15, p = 0.047). Besides, rs117512489 in gene phospholipase B1 gene (PLB1) (HR = 2.02, p = 7.28 × 10-4) was also associated with survival of the patients with NSCLC in our samples, but it was supported only by gene expression analysis in the TCGA (HRadjusted = 1.15, p = 0.023). Gene-based and pathway-based analysis revealed a total of 32 genes, including CCT6A and 34 potential pathways might account for the survival of NSCLC, respectively. CONCLUSION: These results provided more evidence for the important role of low-frequency or rare variants in the survival of patients with NSCLC.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Zhu M, Geng L, Shen W, et al. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients. J Thorac Oncol. 2017. PMID: 28104536. doi:10.1016/j.jtho.2016.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。